DOCSLIB.ORG

Heat Shock Protein 27 Is Involved in SUMO-2&Sol

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Heat Shock Protein 27 Is Involved in SUMO-2&Sol Oncogene (2009) 28, 3332–3344 & 2009 Macmillan Publishers Limited All rights reserved 0950-9232/09 $32.00 www.nature.com/onc ORIGINAL ARTICLE Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity M Brunet Simioni1,2, A De Thonel1,2, A Hammann1,2, AL Joly1,2, G Bossis3,4,5, E Fourmaux1, A Bouchot1, J Landry6, M Piechaczyk3,4,5 and C Garrido1,2,7 1INSERM U866, Dijon, France; 2Faculty of Medicine and Pharmacy, University of Burgundy, Dijon, Burgundy, France; 3Institut de Ge´ne´tique Mole´culaire UMR 5535 CNRS, Montpellier cedex 5, France; 4Universite´ Montpellier 2, Montpellier cedex 5, France; 5Universite´ Montpellier 1, Montpellier cedex 2, France; 6Centre de Recherche en Cance´rologie et De´partement de Me´decine, Universite´ Laval, Quebec City, Que´bec, Canada and 7CHU Dijon BP1542, Dijon, France Heat shock protein 27 (HSP27) accumulates in stressed otherwise lethal conditions. This stress response is cells and helps them to survive adverse conditions. We have universal and is very well conserved through evolution. already shown that HSP27 has a function in the Two of the most stress-inducible HSPs are HSP70 and ubiquitination process that is modulated by its oligomeriza- HSP27. Although HSP70 is an ATP-dependent chaper- tion/phosphorylation status. Here, we show that HSP27 is one induced early after stress and is involved in the also involved in protein sumoylation, a ubiquitination- correct folding of proteins, HSP27 is a late inducible related process. HSP27 increases the number of cell HSP whose main chaperone activity is to inhibit protein proteins modified by small ubiquitin-like modifier aggregation in an ATP-independent manner (Garrido (SUMO)-2/3 but this effect shows some selectivity as it et al., 2006). HSP27 has the ability to form oligomers of neither affects all proteins nor concerns SUMO-1. More- up to 1000 kDa. HSP27 oligomerization is a highly over, no such alteration in SUMO-2/3 conjugation is dynamic process modulated by the phosphorylation of achievable by another HSP, such as HSP70. Heat shock the protein. Human HSP27 can be phosphorylated on factor 1 (HSF1), a transcription factor responsible for HSP three serines (S15, S78 and S82) and the phosphoryla- expression, is one of the targets of HSP27. In stressed cells, tion provokes a shift toward small oligomers (Lambert HSP27 enters the nucleus and, in the form of large et al., 1999; Rogalla et al., 1999). The different activities oligomers, binds to HSF1 and induces its modification by of HSP27 seem to be modulated by the oligomerization SUMO-2/3 on lysine 298. HSP27-induced HSF1 modifica- pattern of the chaperone. We have shown, in vitro and tion by SUMO-2/3 takes place downstream of the in vivo, that large non-phosphorylated oligomers of transcription factor phosphorylation on S303 and S307 HSP27 are responsible for the caspase-dependent anti- and does not affect its DNA-binding ability. In contrast, this apoptotic effect of this chaperone (Bruey et al., 2000). modification blocks HSF1 transactivation capacity. These Other groups have shown that large oligomers are data show that HSP27 exerts a feedback inhibition of needed for HSP27 antioxidant activity (Rogalla et al., HSF1 transactivation and enlighten the strictly regulated 1999). Large non-phosphorylated HSP27 oligomers interplay between HSPs and HSF1. As we also show that bind to actin and the two proteins dissociate HSP27 binds to the SUMO-E2-conjugating enzyme, Ubc9, upon HSP27 phosphorylation (During et al., 2007). our study raises the possibility that HSP27 may act as a In contrast, it is proven that phosphorylated HSP27 SUMO-E3 ligase specific for SUMO-2/3. directly interacts with Daxx (Charette et al., 2000). Oncogene (2009) 28, 3332–3344; doi:10.1038/onc.2009.188; Moreover, small oligomers of HSP27 are also the form published online 13 July 2009 of the protein, which displays affinity for ubiquitin chains and accelerates the degradation of certain Keywords: HSP27; SUMOylation; HSF1; transcriptional proteins under stress conditions (Parcellier et al., activity; stress; cancer 2006). These results suggest that oligomerization/phos- phorylation of the protein alters HSP27 conformation and, hence, determines its capacity to interact with its Introduction different partners. Expression of HSP genes is regulated by the family of Stress or heat shock proteins (HSPs) are induced by the heat shock transcription factors, which bind to the different stresses and help the cells to cope with these heat shock element (HSE) in the promoter region of heat shock genes and, thereby stimulate their transcrip- tion. Three members have been identified in mammals, Correspondence: Dr C Garrido, Faculty of Medicine, INSERM U866, of which heat shock factor 1 (HSF1) is the major stress- 7 boulevard Jeanne d’Arc, 21000 Dijon, Burgundy, France. E-mail: [email protected] responsive family member as no other HSF is able to Received 24 January 2009; revised 17 May 2009; accepted 29 May 2009; functionally substitute for HSF1 or to rescue the published online 13 July 2009 heat shock response in HSF1-deficient cells or mice HSP27 facilitates HSF1 sumoylation M Brunet Simioni et al 3333 (McMillan et al., 1998; Xiao et al., 1999). In response to (Gill, 2003; Hay, 2005). Many transcription factors stressful stimuli such as elevated temperatures, oxidants, such as HSF1 have been shown to be sumoylated and heavy metals, and bacterial or viral infections, HSF1 is this modification, in most cases, impairs the transactiva- activated by trimerization and hyperphosphorylation tion capacity of the substrate (Geiss-Friedlander and (Pirkkala et al., 2001; Holmberg et al., 2002). As a Melchior, 2007). result, HSF1 acquires the ability to bind to HSE and to Heat shock factor 1 has been shown to undergo stress- activate transcription of heat shock genes, which results inducible SUMO-2/3 modification on a conserved lysine, in accumulation of HSPs such as HSP27 and HSP70 K298 (Hietakangas et al., 2003). Further, it has been with, as a final outcome, cell protection (Pirkkala et al., shown that HSF1 has to be previously phosphorylated 2001; Didelot et al., 2006; Garrido et al., 2006; Schmitt on serine 303 for its subsequent sumoylation (Hietakan- et al., 2007; Anckar and Sistonen, 2007a, b). Once the gas et al., 2003). Considering the need of regulated stress conditions are over, HSP gene transcription must chaperone levels in maintaining cellular homoeostasis, immediately stop. HSF1 activity is therefore tightly repression of HSF1 activity by interaction with HSPs is regulated, in particular, through various types of post- essential. The objective of this paper was to study translational modifications. Thus, HSF1 can be phos- whether the main inducible heat shock proteins, HSP70 phorylated at different serine residues (Holmberg et al., or HSP27, have a role in the overall sumoylation process 2001, 2002) and be ubiquitinated (Lee et al., 2008). More and, more particularly, whether they could regulate recently, it has been shown that HSF1 can also be HSF1 sumoylation. We found that HSP27, in the form sumoylated (Hong et al., 2001; Hietakangas et al., 2003, of large oligomers, induced HSF1 SUMO-2/3 modifica- 2006; Anckar et al., 2006). tion and blocked its transactivation capacity. By doing Small ubiquitin-like modifier (SUMO) proteins are so, HSP27 allows a fast and precise modulation of HSP about 100 amino acids in size with a three-dimensional gene transcription, including that of its own gene. structure reminiscent to that of ubiquitin. However, SUMO and ubiquitin share o20% amino acid sequence identity and are different in their overall surface charge Results and Discussion distribution (Geiss-Friedlander and Melchior, 2007). Like ubiquitination, sumoylation results in the forma- HSP27 favours HSF1 modification by SUMO-2/3 tion of an isopeptide bond between the glycine residue To explore whether the two main stress-inducible HSPs, of the modifier protein and the e-amino group of a lysine HSP27 and HSP70, play a role in the sumoylation residue in the acceptor protein. SUMO conjugation process, we assessed their effect on HSF1 modification utilizes a multistep enzymatic pathway, in which by SUMO-2/3. To this aim, we transiently transfected proteolytically processed SUMO initially forms a HeLa cells with a vector for either Myc-tagged wild-type thioester bond with Sae1/2, the E1 SUMO-activating HSF1 (HSF1-wt) or a non-sumoylable HSF1 mutant in enzyme (Johnson, 2004). The SUMO moiety is subse- which K298 has been replaced by arginine (HSF1- quently transferred to Ubc9, the single E2 SUMO- K298R), in the presence or in the absence of vectors for conjugating enzyme, which usually binds directly the haemagglutinin (HA)-tagged HSP27 (HSP27) or HSP70 target protein at the level of sumoylated sites (Geiss- (HSP70) (Figure 1a). SUMO-2/3 modification being Friedlander and Melchior, 2007). E2-substrate interac- inducible by stress (Saitoh and Hinchey, 2000), there- tion may be facilitated by SUMO-E3 factors. The E3 fore, the absence of detection of HSF1 modified by factors increase sumoylation efficiency in a substrate- SUMO-2/3 was not surprising under our experimental specific manner, either by accelerating the transfer of conditions. The only exception for HSF1-SUMO-2/3 SUMO from Ubc9 to the substrate or merely by detection was in cells overexpressing HSP27 and HSF1- providing a scaffold (Guo et al., 2005; Geiss-Friedlander wt, as shown in Figure 1a, left panel, and confirmed on and Melchior, 2007). The SUMO family consists of four the right panel by reversing the immunoprecipitation/ members, SUMO-1, -2, -3 and -4, but SUMO-4 has only immunodetection. As expected, this SUMO-2/3 modi- been detected at the RNA level (Guo et al., 2005; Geiss- fication of HSF1 induced by HSP27 disappeared in cells Friedlander and Melchior, 2007).
Load more

Recommended publications
  • Isoform-Specific Monobody Inhibitors of Small Ubiquitin-Related Modifiers Engineered Using Structure-Guided Library Design
    Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design Ryan N. Gilbretha, Khue Truongb, Ikenna Madub, Akiko Koidea, John B. Wojcika, Nan-Sheng Lia, Joseph A. Piccirillia,c, Yuan Chenb, and Shohei Koidea,1 aDepartment of Biochemistry and Molecular Biology, and cDepartment of Chemistry, University of Chicago, 929 East 57th Street, Chicago, IL 60637; and bDepartment of Molecular Medicine, Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010 Edited by David Baker, University of Washington, Seattle, WA, and approved March 16, 2011 (received for review February 10, 2011) Discriminating closely related molecules remains a major challenge which SUMOylation alters protein function appears to be in the engineering of binding proteins and inhibitors. Here we through SUMO-mediated interactions with other proteins con- report the development of highly selective inhibitors of small ubi- taining a short peptide motif known as a SUMO-interacting motif quitin-related modifier (SUMO) family proteins. SUMOylation is (SIM) (4, 7, 8). involved in the regulation of diverse cellular processes. Functional There are few inhibitors of SUMO/SIM interactions, a defi- differences between two major SUMO isoforms in humans, SUMO1 ciency that limits our ability to finely dissect SUMO biology. In and SUMO2∕3, are thought to arise from distinct interactions the only reported example of such an inhibitor, a SIM-containing mediated by each isoform with other proteins containing SUMO- linear peptide was used to inhibit SUMO/SIM interactions, estab- interacting motifs (SIMs). However, the roles of such isoform- lishing their importance in coordinating DNA repair by nonho- specific interactions are largely uncharacterized due in part to the mologous end joining (9).
    [Show full text]
  • The HECT Domain Ubiquitin Ligase HUWE1 Targets Unassembled Soluble Proteins for Degradation
    OPEN Citation: Cell Discovery (2016) 2, 16040; doi:10.1038/celldisc.2016.40 ARTICLE www.nature.com/celldisc The HECT domain ubiquitin ligase HUWE1 targets unassembled soluble proteins for degradation Yue Xu1, D Eric Anderson2, Yihong Ye1 1Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA; 2Advanced Mass Spectrometry Core Facility, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA In eukaryotes, many proteins function in multi-subunit complexes that require proper assembly. To maintain complex stoichiometry, cells use the endoplasmic reticulum-associated degradation system to degrade unassembled membrane subunits, but how unassembled soluble proteins are eliminated is undefined. Here we show that degradation of unassembled soluble proteins (referred to as unassembled soluble protein degradation, USPD) requires the ubiquitin selective chaperone p97, its co-factor nuclear protein localization protein 4 (Npl4), and the proteasome. At the ubiquitin ligase level, the previously identified protein quality control ligase UBR1 (ubiquitin protein ligase E3 component n-recognin 1) and the related enzymes only process a subset of unassembled soluble proteins. We identify the homologous to the E6-AP carboxyl terminus (homologous to the E6-AP carboxyl terminus) domain-containing protein HUWE1 as a ubiquitin ligase for substrates bearing unshielded, hydrophobic segments. We used a stable isotope labeling with amino acids-based proteomic approach to identify endogenous HUWE1 substrates. Interestingly, many HUWE1 substrates form multi-protein com- plexes that function in the nucleus although HUWE1 itself is cytoplasmically localized. Inhibition of nuclear entry enhances HUWE1-mediated ubiquitination and degradation, suggesting that USPD occurs primarily in the cytoplasm.
    [Show full text]
  • Heat Shock Protein 27 Inhibits HMGB1 Translocation by Regulating CBP
    Molecular Immunology 108 (2019) 45–55 Contents lists available at ScienceDirect Molecular Immunology journal homepage: www.elsevier.com/locate/molimm Heat shock protein 27 inhibits HMGB1 translocation by regulating CBP acetyltransferase activity and ubiquitination T ⁎⁎ Xiaowen Bia, Miao Xua, Jinfei Lia, Ting Huanga, Baolin Jianga, Lei Shena, Lan Luob, , ⁎⁎⁎ ⁎ Shixiang Liuc, , Zhimin Yina, a Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, Jiangsu, PR China b State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, PR China c Jurong People’s Hospital, Zhenjiang, Jiangsu, PR China ARTICLE INFO ABSTRACT Keywords: Heat-shock protein 27 (Hsp27) is a member of the small heat shock protein family that has been reported to Hsp27 protect cells against pro-inflammatory stresses. High mobility group box 1 (HMGB1) is a proinflammatory cy- CBP tokine associated with death from sepsis and other inflammatory diseases. After being acetylated by CREB- HMGB1 binding protein (CBP), the transcriptional adaptor and acetyltransferase, HMGB1 translocates from the nucleus Phosphorylation to the cytoplasm. In the present study, we investigated the effects of Hsp27 on HMGB1 translocation from the Acetylation nucleus to the cytoplasm in THP-1 cells. We found that Hsp27 phosphorylation decreased LPS-induced HMGB1 acetylation and translocation from the nucleus to the cytoplasm, as well as its release from THP-1 cells. The study further showed that cytosolic non-phosphorylated Hsp27 enhanced CBP ubiquitination and degradation in LPS-unstimulated cells, which suggested that Hsp27 maintained suitable CBP levels under normal physiological conditions. After LPS stimulation, Hsp27 was phosphorylated at serine residues 15/78 and translocated from the cytoplasm into the nucleus.
    [Show full text]
  • Roles of Ubiquitination and Sumoylation in the Regulation of Angiogenesis
    Curr. Issues Mol. Biol. (2020) 35: 109-126. Roles of Ubiquitination and SUMOylation in the Regulation of Angiogenesis Andrea Rabellino1*, Cristina Andreani2 and Pier Paolo Scaglioni2 1QIMR Berghofer Medical Research Institute, Brisbane City, Queensland, Australia. 2Department of Internal Medicine, Hematology and Oncology; University of Cincinnati, Cincinnati, OH, USA. *Correspondence: [email protected] htps://doi.org/10.21775/cimb.035.109 Abstract is tumorigenesis-induced angiogenesis, during Te generation of new blood vessels from the which hypoxic and starved cancer cells activate existing vasculature is a dynamic and complex the molecular pathways involved in the formation mechanism known as angiogenesis. Angiogenesis of novel blood vessels, in order to supply nutri- occurs during the entire lifespan of vertebrates and ents and oxygen required for the tumour growth. participates in many physiological processes. Fur- Additionally, more than 70 diferent disorders have thermore, angiogenesis is also actively involved been associated to de novo angiogenesis including in many human diseases and disorders, including obesity, bacterial infections and AIDS (Carmeliet, cancer, obesity and infections. Several inter-con- 2003). nected molecular pathways regulate angiogenesis, At the molecular level, angiogenesis relays on and post-translational modifcations, such as phos- several pathways that cooperate in order to regulate phorylation, ubiquitination and SUMOylation, in a precise spatial and temporal order the process. tightly regulate these mechanisms and play a key In this context, post-translational modifcations role in the control of the process. Here, we describe (PTMs) play a central role in the regulation of these in detail the roles of ubiquitination and SUMOyla- events, infuencing the activation and stability of tion in the regulation of angiogenesis.
    [Show full text]
  • BC-Box Protein Domain-Related Mechanism for VHL Protein Degradation
    BC-box protein domain-related mechanism for VHL protein degradation Maria Elena Pozzebona,1,2, Archana Varadaraja,1, Domenico Mattoscioa, Ellis G. Jaffrayb, Claudia Miccoloa, Viviana Galimbertic, Massimo Tommasinod, Ronald T. Hayb, and Susanna Chioccaa,3 aDepartment of Experimental Oncology, European Institute of Oncology, 20139 Milan, Italy; cSenology Division, European Institute of Oncology, 20141 Milan, Italy; dInternational Agency for Research on Cancer, World Health Organization, 69372 Lyon, France; and bCentre for Gene Regulation and Expression, University of Dundee, Dundee DD1 5EH, United Kingdom Edited by William G. Kaelin, Jr., Harvard Medical School, Boston, MA, and approved September 23, 2013 (received for review June 18, 2013) The tumor suppressor VHL (von Hippel–Lindau) protein is a sub- effects of the wild-type Gam1 protein (18, 20, 21), supporting the strate receptor for Ubiquitin Cullin Ring Ligase complexes (CRLs), idea that these effects may depend on Gam1 ability to act as containing a BC-box domain that associates to the adaptor Elongin substrate-receptor protein. B/C. VHL targets hypoxia-inducible factor 1α to proteasome- VHL (von Hippel–Lindau) protein is a cellular BC box-con- dependent degradation. Gam1 is an adenoviral protein, which also taining substrate receptor and associates with Cullin2-based E3 possesses a BC-box domain that interacts with the host Elongin B/C, ligases (22–24). VHL is a tumor suppressor, and its loss leads to – thereby acting as a viral substrate receptor. Gam1 associates with the von Hippel Lindau syndrome that often develops into renal both Cullin2 and Cullin5 to form CRL complexes targeting the host clear-cell carcinoma and other highly vascularized tumors (25, 26).
    [Show full text]
  • Yichen – Structure and Allostery of the Chaperonin Groel. Allosteric
    Literature Lunch 5-1-13 Yichen – J Mol Biol. 2013 May 13;425(9):1476-87. doi: 10.1016/j.jmb.2012.11.028. Epub 2012 Nov 24. Structure and Allostery of the Chaperonin GroEL. Saibil HR, Fenton WA, Clare DK, Horwich AL. Source Crystallography and Institute of Structural and Molecular Biology, Birkbeck College London, Malet Street, London WC1E 7HX, UK. Abstract Chaperonins are intricate allosteric machines formed of two back-to-back, stacked rings of subunits presenting end cavities lined with hydrophobic binding sites for nonnative polypeptides. Once bound, substrates are subjected to forceful, concerted movements that result in their ejection from the binding surface and simultaneous encapsulation inside a hydrophilic chamber that favors their folding. Here, we review the allosteric machine movements that are choreographed by ATP binding, which triggers concerted tilting and twisting of subunit domains. These movements distort the ring of hydrophobic binding sites and split it apart, potentially unfolding the multiply bound substrate. Then, GroES binding is accompanied by a 100° twist of the binding domains that removes the hydrophobic sites from the cavity lining and forms the folding chamber. ATP hydrolysis is not needed for a single round of binding and encapsulation but is necessary to allow the next round of ATP binding in the opposite ring. It is this remote ATP binding that triggers dismantling of the folding chamber and release of the encapsulated substrate, whether folded or not. The basis for these ordered actions is an elegant system of nested cooperativity of the ATPase machinery. ATP binds to a ring with positive cooperativity, and movements of the interlinked subunit domains are concerted.
    [Show full text]
  • Genome-Wide Sirna Screen for Mediators of NF-Κb Activation
    Genome-wide siRNA screen for mediators SEE COMMENTARY of NF-κB activation Benjamin E. Gewurza, Fadi Towficb,c,1, Jessica C. Marb,d,1, Nicholas P. Shinnersa,1, Kaoru Takasakia, Bo Zhaoa, Ellen D. Cahir-McFarlanda, John Quackenbushe, Ramnik J. Xavierb,c, and Elliott Kieffa,2 aDepartment of Medicine and Microbiology and Molecular Genetics, Channing Laboratory, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; bCenter for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; cProgram in Medical and Population Genetics, The Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142; dDepartment of Biostatistics, Harvard School of Public Health, Boston, MA 02115; and eDepartment of Biostatistics and Computational Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115 Contributed by Elliott Kieff, December 16, 2011 (sent for review October 2, 2011) Although canonical NFκB is frequently critical for cell proliferation, (RIPK1). TRADD engages TNFR-associated factor 2 (TRAF2), survival, or differentiation, NFκB hyperactivation can cause malig- which recruits the ubiquitin (Ub) E2 ligase UBC5 and the E3 nant, inflammatory, or autoimmune disorders. Despite intensive ligases cIAP1 and cIAP2. CIAP1/2 polyubiquitinate RIPK1 and study, mammalian NFκB pathway loss-of-function RNAi analyses TRAF2, which recruit and activate the K63-Ub binding proteins have been limited to specific protein classes. We therefore under- TAB1, TAB2, and TAB3, as well as their associated kinase took a human genome-wide siRNA screen for novel NFκB activa- MAP3K7 (TAK1). TAK1 in turn phosphorylates IKKβ activa- tion pathway components. Using an Epstein Barr virus latent tion loop serines to promote IKK activity (4).
    [Show full text]
  • Supplementary Table S5. Differentially Expressed Gene Lists of PD-1High CD39+ CD8 Tils According to 4-1BB Expression Compared to PD-1+ CD39- CD8 Tils
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Immunother Cancer Supplementary Table S5. Differentially expressed gene lists of PD-1high CD39+ CD8 TILs according to 4-1BB expression compared to PD-1+ CD39- CD8 TILs Up- or down- regulated genes in Up- or down- regulated genes Up- or down- regulated genes only PD-1high CD39+ CD8 TILs only in 4-1BBneg PD-1high CD39+ in 4-1BBpos PD-1high CD39+ CD8 compared to PD-1+ CD39- CD8 CD8 TILs compared to PD-1+ TILs compared to PD-1+ CD39- TILs CD39- CD8 TILs CD8 TILs IL7R KLRG1 TNFSF4 ENTPD1 DHRS3 LEF1 ITGA5 MKI67 PZP KLF3 RYR2 SIK1B ANK3 LYST PPP1R3B ETV1 ADAM28 H2AC13 CCR7 GFOD1 RASGRP2 ITGAX MAST4 RAD51AP1 MYO1E CLCF1 NEBL S1PR5 VCL MPP7 MS4A6A PHLDB1 GFPT2 TNF RPL3 SPRY4 VCAM1 B4GALT5 TIPARP TNS3 PDCD1 POLQ AKAP5 IL6ST LY9 PLXND1 PLEKHA1 NEU1 DGKH SPRY2 PLEKHG3 IKZF4 MTX3 PARK7 ATP8B4 SYT11 PTGER4 SORL1 RAB11FIP5 BRCA1 MAP4K3 NCR1 CCR4 S1PR1 PDE8A IFIT2 EPHA4 ARHGEF12 PAICS PELI2 LAT2 GPRASP1 TTN RPLP0 IL4I1 AUTS2 RPS3 CDCA3 NHS LONRF2 CDC42EP3 SLCO3A1 RRM2 ADAMTSL4 INPP5F ARHGAP31 ESCO2 ADRB2 CSF1 WDHD1 GOLIM4 CDK5RAP1 CD69 GLUL HJURP SHC4 GNLY TTC9 HELLS DPP4 IL23A PITPNC1 TOX ARHGEF9 EXO1 SLC4A4 CKAP4 CARMIL3 NHSL2 DZIP3 GINS1 FUT8 UBASH3B CDCA5 PDE7B SOGA1 CDC45 NR3C2 TRIB1 KIF14 TRAF5 LIMS1 PPP1R2C TNFRSF9 KLRC2 POLA1 CD80 ATP10D CDCA8 SETD7 IER2 PATL2 CCDC141 CD84 HSPA6 CYB561 MPHOSPH9 CLSPN KLRC1 PTMS SCML4 ZBTB10 CCL3 CA5B PIP5K1B WNT9A CCNH GEM IL18RAP GGH SARDH B3GNT7 C13orf46 SBF2 IKZF3 ZMAT1 TCF7 NECTIN1 H3C7 FOS PAG1 HECA SLC4A10 SLC35G2 PER1 P2RY1 NFKBIA WDR76 PLAUR KDM1A H1-5 TSHZ2 FAM102B HMMR GPR132 CCRL2 PARP8 A2M ST8SIA1 NUF2 IL5RA RBPMS UBE2T USP53 EEF1A1 PLAC8 LGR6 TMEM123 NEK2 SNAP47 PTGIS SH2B3 P2RY8 S100PBP PLEKHA7 CLNK CRIM1 MGAT5 YBX3 TP53INP1 DTL CFH FEZ1 MYB FRMD4B TSPAN5 STIL ITGA2 GOLGA6L10 MYBL2 AHI1 CAND2 GZMB RBPJ PELI1 HSPA1B KCNK5 GOLGA6L9 TICRR TPRG1 UBE2C AURKA Leem G, et al.
    [Show full text]
  • At Elevated Temperatures, Heat Shock Protein Genes Show Altered Ratios Of
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 22: 900, 2021 At elevated temperatures, heat shock protein genes show altered ratios of different RNAs and expression of new RNAs, including several novel HSPB1 mRNAs encoding HSP27 protein isoforms XIA GAO1,2, KEYIN ZHANG1,2, HAIYAN ZHOU3, LUCAS ZELLMER4, CHENGFU YUAN5, HAI HUANG6 and DEZHONG JOSHUA LIAO2,6 1Department of Pathology, Guizhou Medical University Hospital; 2Key Lab of Endemic and Ethnic Diseases of The Ministry of Education of China in Guizhou Medical University; 3Clinical Research Center, Guizhou Medical University Hospital, Guiyang, Guizhou 550004, P.R. China; 4Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; 5Department of Biochemistry, China Three Gorges University, Yichang, Hubei 443002; 6Center for Clinical Laboratories, Guizhou Medical University Hospital, Guiyang, Guizhou 550004, P.R. China Received December 16, 2020; Accepted May 10, 2021 DOI: 10.3892/etm.2021.10332 Abstract. Heat shock proteins (HSP) serve as chaperones genes may engender multiple protein isoforms. These results to maintain the physiological conformation and function of collectively suggested that, besides increasing their expres‑ numerous cellular proteins when the ambient temperature is sion, certain HSP and associated genes also use alternative increased. To determine how accurate the general assumption transcription start sites to produce multiple RNA transcripts that HSP gene expression is increased in febrile situations is, and use alternative splicing of a transcript to produce multiple the RNA levels of the HSF1 (heat shock transcription factor 1) mature RNAs, as important mechanisms for responding to an gene and certain HSP genes were determined in three cell increased ambient temperature in vitro. lines cultured at 37˚C or 39˚C for three days.
    [Show full text]
  • Understanding and Exploiting Post-Translational Modifications for Plant Disease Resistance
    biomolecules Review Understanding and Exploiting Post-Translational Modifications for Plant Disease Resistance Catherine Gough and Ari Sadanandom * Department of Biosciences, Durham University, Stockton Road, Durham DH1 3LE, UK; [email protected] * Correspondence: [email protected]; Tel.: +44-1913341263 Abstract: Plants are constantly threatened by pathogens, so have evolved complex defence signalling networks to overcome pathogen attacks. Post-translational modifications (PTMs) are fundamental to plant immunity, allowing rapid and dynamic responses at the appropriate time. PTM regulation is essential; pathogen effectors often disrupt PTMs in an attempt to evade immune responses. Here, we cover the mechanisms of disease resistance to pathogens, and how growth is balanced with defence, with a focus on the essential roles of PTMs. Alteration of defence-related PTMs has the potential to fine-tune molecular interactions to produce disease-resistant crops, without trade-offs in growth and fitness. Keywords: post-translational modifications; plant immunity; phosphorylation; ubiquitination; SUMOylation; defence Citation: Gough, C.; Sadanandom, A. 1. Introduction Understanding and Exploiting Plant growth and survival are constantly threatened by biotic stress, including plant Post-Translational Modifications for pathogens consisting of viruses, bacteria, fungi, and chromista. In the context of agriculture, Plant Disease Resistance. Biomolecules crop yield losses due to pathogens are estimated to be around 20% worldwide in staple 2021, 11, 1122. https://doi.org/ crops [1]. The spread of pests and diseases into new environments is increasing: more 10.3390/biom11081122 extreme weather events associated with climate change create favourable environments for food- and water-borne pathogens [2,3]. Academic Editors: Giovanna Serino The significant estimates of crop losses from pathogens highlight the need to de- and Daisuke Todaka velop crops with disease-resistance traits against current and emerging pathogens.
    [Show full text]
  • Functional and Physical Interaction Between Yeast Hsp90 and Hsp70
    Functional and physical interaction between yeast PNAS PLUS Hsp90 and Hsp70 Andrea N. Kravatsa, Joel R. Hoskinsa, Michael Reidyb, Jill L. Johnsonc, Shannon M. Doylea, Olivier Genesta,1, Daniel C. Masisonb, and Sue Wicknera,2 aLaboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; bLaboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; and cDepartment of Biological Sciences, University of Idaho, Moscow, ID 83844 Contributed by Sue Wickner, January 25, 2018 (sent for review November 17, 2017; reviewed by Daniel N. A. Bolon and Jeffrey L. Brodsky) Heat shock protein 90 (Hsp90) is a highly conserved ATP-dependent changes in response to ATP binding, hydrolysis, and ADP release molecular chaperone that is essential in eukaryotes. It is required for (1,3,6,14–16). In the absence of ATP, the Hsp90 dimer acquires the activation and stabilization of more than 200 client proteins, an open, V-shaped structure such that the protomers interact via including many kinases and steroid hormone receptors involved in the C-terminal dimerization domain (16). When ATP is bound, the cell-signaling pathways. Hsp90 chaperone activity requires collabo- protein takes on a closed conformation with the two N-domains of ration with a subset of the many Hsp90 cochaperones, including the the dimer interacting and a portion of the N-domain, the “lid,” Hsp70 chaperone. In higher eukaryotes, the collaboration between closing over the nucleotide in each protomer (16, 17). Additional Hsp90 and Hsp70 is indirect and involves Hop, a cochaperone that conformational changes occur upon ATP hydrolysis, resulting in a interacts with both Hsp90 and Hsp70.
    [Show full text]
  • Ginkgolic Acid, a Sumoylation Inhibitor, Promotes Adipocyte
    www.nature.com/scientificreports OPEN Ginkgolic acid, a sumoylation inhibitor, promotes adipocyte commitment but suppresses Received: 25 October 2017 Accepted: 15 January 2018 adipocyte terminal diferentiation Published: xx xx xxxx of mouse bone marrow stromal cells Huadie Liu1,2, Jianshuang Li2, Di Lu2, Jie Li1,2, Minmin Liu 3, Yuanzheng He4, Bart O. Williams2, Jiada Li1 & Tao Yang 2 Sumoylation is a post-translational modifcation process having an important infuence in mesenchymal stem cell (MSC) diferentiation. Thus, sumoylation-modulating chemicals might be used to control MSC diferentiation for skeletal tissue engineering. In this work, we studied how the diferentiation of mouse bone marrow stromal cells (mBMSCs) is afected by ginkgolic acid (GA), a potent sumoylation inhibitor also reported to inhibit histone acetylation transferase (HAT). Our results show that GA promoted the diferentiation of mBMSCs into adipocytes when cultured in osteogenic medium. Moreover, mBMSCs pre-treated with GA showed enhanced pre-adipogenic gene expression and were more efciently diferentiated into adipocytes when subsequently cultured in the adipogenic medium. However, when GA was added at a later stage of adipogenesis, adipocyte maturation was markedly inhibited, with a dramatic down-regulation of multiple lipogenesis genes. Moreover, we found that the efects of garcinol, a HAT inhibitor, difered from those of GA in regulating adipocyte commitment and adipocyte maturation of mBMSCs, implying that the GA function in adipogenesis is likely through its activity as a sumoylation inhibitor, not as a HAT inhibitor. Overall, our studies revealed an unprecedented role of GA in MSC diferentiation and provide new mechanistic insights into the use of GA in clinical applications.
    [Show full text]